Radiofrequency ablation (RFA) is proven to effectively ablate greater saphenous vein (GSV) reflux. It is a safe, effective alternative to stripping the GSV, the small saphenous vein, and accessory saphenous veins. The use of computer-controlled feedback for controlled application of bipolar electrothermal energy has been the primary RFA modality since 2001, but recently specialized catheters have become available for thermal ablation.
In a recent presentation, Paul McNeill, MD, discussed RFA and compared two RFA systems. Vein Global subscribers can access a video of his lecture on the subject at a meeting of the International Vein Congress.
Background on Radiofrequency AblationRFA is minimally invasive and takes about 30 minutes to 1 hour to complete. It is performed with tumescent anesthesia and requires a minimal recovery time. Complications after the procedure are rare and generally temporary.
Some problems can occur in RFA. These affect approximately 1% of patients:
RFA generally improves patients’ quality of life, decreases the venous clinical severity score (VCSS), and brings about reversion to a lower CEAP (clinical, etiologic, anatomic, and pathophysiologic) class afterward. Patients experience minimal discomfort during and after the procedure.
There are a few contraindications to RFA:
Endovenous RFA was first approved by the US Food and Drug Administration (FDA) in 1999, and the first promising reports of its use were published in 2000.
In this video presentation, Dr. McNeill reviews several device options for performing radiofrequency ablation. There are nuanced differences in feature specs across the various devices as outlined by Dr. McNeill.
A subscription to Veinglobal.com provides access to more than 200 on-demand instructional, inspirational, and innovative presentations on surgical procedures, practice management, research data, and more. Vein Global is a tool for your entire practice to stay current on venous education.